Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $8.2000 (1.61%) ($7.8200 - $8.4200) on Wed. Aug. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.44% (three month average) | RSI | 75 | Latest Price | $8.2000(1.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 13.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BND(48%) BWX(16%) TLT(15%) CEMB(13%) SIL(12%) | Factors Impacting CAPR price | CAPR will decline at least -4.22% in a week (0% probabilities). XOP(-22%) EDOC(-22%) XLI(-20%) XLF(-20%) XLB(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.22% (StdDev 8.44%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
5 Day Moving Average | $7.89(3.93%) | 10 Day Moving Average | $8.18(0.24%) | 20 Day Moving Average | $6.73(21.84%) | To recent high | -16.4% | To recent low | 63.7% | Market Cap | $162m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |